Form 8-K - Current report:
SEC Accession No. 0001279569-21-001784
Filing Date
2021-12-10
Accepted
2021-12-10 16:20:20
Documents
13
Period of Report
2021-12-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 32686
  Complete submission text file 0001279569-21-001784.txt   230955

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20211207.xsd EX-101.SCH 3104
3 XBRL DEFINITION FILE ffntf-20211207_def.xml EX-101.DEF 26260
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20211207_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20211207_pre.xml EX-101.PRE 22372
6 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3569
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 211485596
SIC: 2833 Medicinal Chemicals & Botanical Products